April 30, 2024
3:30PM - 4:30PM
Psychology Building 035
Add to Calendar
2024-04-30 15:30:00
2024-04-30 16:30:00
Department Speakers Committee Presents Professor Barbara Andersen
Translational Biobehavioral Research in CancerIn an Institute of Medicine report, Crossing the quality chasm: A new health system for the 21st century, the lag time in translation between basic research to health care practice implementation was estimated to be 20 years, with one factor being the failure to move treatment development and testing to scaled up implementations. Translational science discoveries and theoretical linkages leading to improved patient health will be discussed, with clinical and research illustrations from gynecologic and breast cancers, chronic lymphocytic leukemia, and advanced lung cancer.
Psychology Building 035
OSU ASC Drupal 8
ascwebservices@osu.edu
America/New_York
public
Date Range
Add to Calendar
2024-04-30 15:30:00
2024-04-30 16:30:00
Department Speakers Committee Presents Professor Barbara Andersen
Translational Biobehavioral Research in CancerIn an Institute of Medicine report, Crossing the quality chasm: A new health system for the 21st century, the lag time in translation between basic research to health care practice implementation was estimated to be 20 years, with one factor being the failure to move treatment development and testing to scaled up implementations. Translational science discoveries and theoretical linkages leading to improved patient health will be discussed, with clinical and research illustrations from gynecologic and breast cancers, chronic lymphocytic leukemia, and advanced lung cancer.
Psychology Building 035
Department of Psychology
ASC-psychmainoffice@osu.edu
America/New_York
public
Translational Biobehavioral Research in Cancer
In an Institute of Medicine report, Crossing the quality chasm: A new health system for the 21st century, the lag time in translation between basic research to health care practice implementation was estimated to be 20 years, with one factor being the failure to move treatment development and testing to scaled up implementations. Translational science discoveries and theoretical linkages leading to improved patient health will be discussed, with clinical and research illustrations from gynecologic and breast cancers, chronic lymphocytic leukemia, and advanced lung cancer.
